Forum Update: Supporting Community-Led Discussion
The forum was created as a space for shared learning and peer support, and as the community grows, we want to lean more fully into that purpose.
Going forward, PAAB will be taking a more listening-first role in forum discussions. Rather than responding immediately to every question, we’ll be encouraging members to engage with one another, share experiences, and help build collective understanding. PAAB will continue to monitor conversations and will step in to:
- Correct any misunderstandings
- Provide guidance when questions remain unanswered after a few days
- Support discussions where official clarification is needed
Our goal is to foster a collaborative, trusted community where knowledge is shared and strengthened by everyone’s contributions.
Thank you for being part of the conversation.
Schedule 2 products, DTC, and linkage oh my!
-
Hi, I have a question regarding schedule 2 (nonprescription, but regulated by Heath Canada) products, specifically a biologic. Is it permissible to link from a DTC site (ungated) to the complete, unedited product monograph? Also, does the 2023 Guidance on the distinction between advertising and other activity, which now specifically mentions biologics, affect the review of this type of product?
-
Hi, I have a question regarding schedule 2 (nonprescription, but regulated by Heath Canada) products, specifically a biologic. Is it permissible to link from a DTC site (ungated) to the complete, unedited product monograph? Also, does the 2023 Guidance on the distinction between advertising and other activity, which now specifically mentions biologics, affect the review of this type of product?
Hello. As the example does not specify the product, we are unable to answer the question directly. The product, therapeutic area and Health Canada product schedule will determine which regulations apply in the DTC space. We direct you to the Food and Drugs regulations and the document Guidance Document: Schedule A and Section 3 to the Food and Drugs Act. It will provide clarification on advertising restrictions to the general public. Please note section 3 and 2.3 of the document regarding Schedule A diseases in advertising. Linking a DTC website even to an unedited PM may be a violation of the regulations depending on the therapeutic area. We suggest contacting PAAB for a general question call should you need further clarification. Please also note that the DTC site is considered promotional advertising so the Distinction document does not apply in this scenario.
